Published in Gut on June 01, 1976
Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity (Silver Spring) (2009) 3.15
Serum bile acids in the diagnosis of hepatobiliary disease. Gut (1977) 1.63
Diagnostic value of serum primary bile acids in detecting bile acid malabsorption. Gut (1982) 1.16
Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids. Gut (1977) 1.08
Serum bile acids in hepatobiliary disease. Gut (1978) 1.06
Effect of prolonged feeding with chenodeoxycholic acid on bile in patients with and without gallstones. Gut (1977) 1.04
Serum bile acids in patients with hyperlipidaemia. J Clin Pathol (1978) 0.95
Physiological factors influencing serum bile acid levels. Gut (1978) 0.89
Apparent selective bile acid malabsorption as a consequence of ileal exclusion: effects on bile acid, cholesterol, and lipoprotein metabolism. Gut (1994) 0.87
Enterohepatic circulation rates of cholic acid and chenodeoxycholic acid in man. Gut (1979) 0.84
Metabolic surgery-principles and current concepts. Langenbecks Arch Surg (2011) 0.80
A rapid screening test for reduced fibrinolytic activity of plasma: streptokinase activated lysis time. J Clin Pathol (1978) 0.75
Biliary lipid metabolism in chronic pancreatitis: influence of steatorrhoea. Gut (1987) 0.75
Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58
Characterization of the kinetics of the passive and active transport mechanisms for bile acid absorption in the small intestine and colon of the rat. J Clin Invest (1972) 2.00
Mechanisms for the intestinal absorption of bile acids. J Lipid Res (1968) 1.92
Active and passive bile acid absorption in man. Perfusion studies of the ileum and jejunum. J Clin Invest (1974) 1.62
Bile acid pools, kinetics and biliary lipid composition before and after cholecystectomy. N Engl J Med (1973) 1.56
The effect of cholecystectomy on bile salt metabolism. Gut (1973) 1.56
Metabolism of steroid and amino acid moieties of conjugated bile acids in man. II. Glycine-conjugated dihydroxy bile acids. J Clin Invest (1972) 1.50
Increased bacterial degradation of bile acids in cholecystectomized patients. Gastroenterology (1974) 1.27
Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;. J Clin Invest (1974) 1.21
Effect of cholestyramine on bile acid metabolism in normal man. J Clin Invest (1972) 1.07
Studies on human bile. V. Influence of cholestyramine treatment on the composition of bile in healthy subjects. Z Ernahrungswiss (1971) 1.06
Measurement and validation of human bile salt pool size and synthesis. Clin Chim Acta (1974) 0.99
The formation of deoxycholic acid and chenodeoxycholic acid in man. Clin Sci Mol Med (1974) 0.89
Effect of cholestyramine on composition of duodenal bile in obese human subjects. Metabolism (1972) 0.88
Effect of cholic acid feeding on bile acid kinetics and neutral fecal steroid excretion in hyperlipoproteinemia (types II and IV). Metabolism (1974) 0.87
Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med (2006) 2.70
Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia. Lancet (1990) 2.55
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. Circulation (1999) 2.27
Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med (1990) 2.06
Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J Clin Invest (2001) 1.95
Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochem Biophys Res Commun (2000) 1.94
Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene (2009) 1.92
One-Session treatment of specific phobias in youths: a randomized clinical trial. J Consult Clin Psychol (2001) 1.70
Walking training of patients with hemiparesis at an early stage after stroke: a comparison of walking training on a treadmill with body weight support and walking training on the ground. Clin Rehabil (2001) 1.69
Ceftriaxone: renal and biliary excretion and effect on the colon microflora. J Antimicrob Chemother (1982) 1.65
Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J Clin Invest (1982) 1.61
Prevalence of hypercalcaemia in a health screening in Stockholm. Acta Med Scand (1976) 1.61
Blood pressure in subjects with hypercalcaemia and primary hyperparathyroidism detected in a health screening programme. Eur J Clin Invest (1977) 1.54
Effect of biliary drainage on individual reactions in the conversion of cholesterol to taurochlic acid. Bile acids and steroids 180. Eur J Biochem (1967) 1.54
Bile acid kinetics and biliary lipid composition in cystic fibrosis. J Hepatol (1996) 1.51
Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia. Am J Med (1993) 1.50
Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res (1987) 1.50
The effect of plasma low density lipoprotein apheresis on the hepatic secretion of biliary lipids in humans. Gut (1997) 1.49
Risk for fatal statin-induced rhabdomyolysis as a consequence of misinterpretation of 'evidence-based medicine'. J Intern Med (2005) 1.48
Biliary lipid composition during treatment with different hypolipidaemic drugs. Eur J Clin Invest (1979) 1.48
Secretion and composition of bile after human liver transplantation: studies on the effects of cyclosporine and tacrolimus. Transplantation (1997) 1.43
Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. J Lipid Res (1978) 1.35
Type III hyperlipoproteinemia: recent insights into the genetic defect of familial dysbetalipoproteinemia. Adv Intern Med (1984) 1.34
Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci U S A (1992) 1.34
Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med (1985) 1.28
The absorption of orally administered (12 - 3 H)digoxin in man. Clin Sci (1972) 1.28
On the conversion of cholesterol to 7-alpha,12-alpha-dihydroxycholest-4-en-3-one. Bile acids and steroids 168. J Biol Chem (1966) 1.26
Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment. J Intern Med (2004) 1.26
Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system. Eur J Clin Invest (2006) 1.26
Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arterioscler Thromb Vasc Biol (1996) 1.23
Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol. Mol Endocrinol (2000) 1.22
Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids. J Clin Invest (1983) 1.22
Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;. J Clin Invest (1974) 1.21
Individual bile acids in portal venous and systemic blood serum of fasting man. Gastroenterology (1977) 1.20
Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides. Metabolism (1982) 1.19
Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. J Intern Med (2011) 1.17
The gastrointestinal absorption and the excretion of H3-butylscopolamine (hyoscine butylbromide) in man. Scand J Gastroenterol (1970) 1.17
Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia. J Clin Invest (1995) 1.16
Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proc Natl Acad Sci U S A (1990) 1.15
Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest (1992) 1.13
Low density lipoprotein receptor-binding activity in human tissues: quantitative importance of hepatic receptors and evidence for regulation of their expression in vivo. Proc Natl Acad Sci U S A (1990) 1.13
Interindividual variability in biliary excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microflora. Eur J Clin Invest (1988) 1.11
Evaluation of refractory epilepsy treated with vagus nerve stimulation for up to 5 years. Neurology (1999) 1.10
Neonatal imprinting of liver microsomal hydroxylation and reduction of steroids. J Biol Chem (1973) 1.08
Gallbladder disease in hyperlipoproteinaemia. Lancet (1975) 1.08
Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids. Gut (1977) 1.08
Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J Clin Invest (1991) 1.07
Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones. Gut (1990) 1.07
Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. Neurosci Lett (1994) 1.06
Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Br J Psychiatry (2001) 1.05
Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels. J Intern Med (1990) 1.05
Biliary lipid composition in normo- and hyperlipoproteinemia. Gastroenterology (1980) 1.04
Influence of deoxycholic acid on biliary lipids in man. Clin Sci Mol Med (1977) 1.03
Neurophysiologic studies of patients with Crohn's disease on long-term treatment with metronidazole. Scand J Gastroenterol (1991) 1.03
On the metabolism of propantheline in man. Clin Pharmacol Ther (1972) 1.02
The plasma level of 7 alpha-hydroxy-4-cholesten-3-one reflects the activity of hepatic cholesterol 7 alpha-hydroxylase in man. FEBS Lett (1991) 1.02
Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study. Scand J Gastroenterol (1997) 1.02
Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis. Gastroenterology (1983) 1.02
Studies of liver insulin receptors in non-obese and obese human subjects. J Clin Invest (1983) 1.01
14C-triolein breath test as a rapid and convenient screening test for fat malabsorption. Scand J Gastroenterol (1983) 1.01
Hypocalcaemia with zonular cataract due to idiopathic hypoparathyroidism. With a note on the prevalence of severe hypocalcaemia in a health screening. Acta Med Scand (1978) 1.00
Stimulation of rat hepatic low density lipoprotein receptors by glucagon. Evidence of a novel regulatory mechanism in vivo. J Clin Invest (1993) 1.00
Hepatic cholesterol metabolism in human obesity. Hepatology (1997) 0.99
Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment. J Lipid Res (1981) 0.99
Individual serum bile acid concentrations in normo- and hyperlipoproteinemia as determined by mass fragmentography: relation to bile acid pool size. J Lipid Res (1978) 0.99
Formation of bile acids in man: conversion of cholesterol into 5-beta-cholestane-3-alpha, 7-alpha, 12-alpha-triol in liver homogenates. J Clin Invest (1968) 0.99
Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of cholestyramine on HMG-CoA reductase activity and low density lipoprotein receptor expression in gallstone patients. J Lipid Res (1990) 0.98
Low density lipoprotein receptor activity in human intracranial tumors and its relation to the cholesterol requirement. Cancer Res (1990) 0.98
On the possible use of the serum level of 7 alpha-hydroxycholesterol as a marker for increased activity of the cholesterol 7 alpha-hydroxylase in humans. J Lipid Res (1987) 0.97
Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem (1993) 0.97
Effect of aging on free amino acids and electrolytes in leg skeletal muscle. Clin Sci (Lond) (1979) 0.96
Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment. Scand J Infect Dis (1991) 0.96
Hepatic metabolism of cholesterol in Crohn's disease. Effect of partial resection of ileum. Gastroenterology (1991) 0.95